Japanese pharma Eisai slides 4% despite FDA approval for… Signage for Eisai Co. at the company's headquarters in Tokyo, Japan, on Friday, Feb.… Read More...
Alzheimer’s patients retain the benefits of Leqembi even when they… Research at BiogenSource: BiogenAlzheimer's patients who take Leqembi retain the… Read More...
Experimental Alzheimer’s drug slows disease, researchers say. Will it… An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable… Read More...
